Search for: "H. LUNDBECK A/S v. LUPIN LTD. "
Results 1 - 11
of 11
Sorted by Relevance
|
Sort by Date
18 Dec 2023, 9:07 pm
Lundbeck A/S v. [read post]
25 Jan 2024, 8:25 pm
Lundbeck A/S v. [read post]
7 Jan 2024, 9:59 pm
Lundbeck A/S v. [read post]
18 Jan 2024, 9:16 am
Lundbeck A/S, et al. v. [read post]
7 Dec 2023, 1:47 pm
Lundbeck A/S v. [read post]
11 Dec 2023, 7:43 am
Lundbeck A/S v. [read post]
14 Jul 2010, 6:47 pm
Glaxo tries a ‘Linux’ (Spicy IP) TB Alliance and DNDi team up to fight neglected diseases (IP Watch) Australia: Pharmaceuticals extensions and international inequities: H Lundbeck A/S v Alphapharm Pty Ltd, Ortho-McNeil Pharmaceutical, Inc v Lupin Pharmaceuticals, Inc (Patentology) Australia: The ‘morality’ of gene patents (Patentology) Belgium: Antwerp commercial court finds Belgian counterpart of EU patent… [read post]
15 Jun 2011, 4:56 am
Lupin Ltd. et al. [read post]
13 May 2010, 4:58 pm
Lundbeck A/S v. [read post]
18 Apr 2008, 2:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Ranbaxy and AstraZeneca reach agreement in Esomeprazole patent litigation: (SmartBrief), (IPBiz), (Spicy IP), (Profitability through Simplicity), (IP Law360), (Philip Brooks), (GenericsWeb), Cadbury loses Australian battle over exclusive use of colour purple for chocolate wrapping in its case against Darrell Lea: (Australian Trade Marks Law… [read post]
2 May 2008, 7:00 am
: (Patent Baristas), US: How to avoid a permanent injunction: the lessons of Amgen v Hoffman-LaRoche: (Patent Docs), US: Jarvik Heart’s PTE request based on PMA shell/module submission dates flatlines; ruling on initiation of PTE ‘review period’ mirrors FDA policy for ‘fast track’ products: (FDA Law Blog) Pharma & Biotech - Products Kytril (Granisetron) – Exclusivity ‘parking’… [read post]
